Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-12-063575

Options or other derivatives

  • Director acquired 585,152 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Waksal Harlan · Director

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2012-11-16 Grant or award : show line 1 in the form Common Stock Options +420,000 $0.17 2022-11-16 420,000 2,122,330 D
2012-11-16 Grant or award : show line 2 in the form Common Stock Options +165,152 $0.17 2022-11-16 165,152 2,287,482 D
Loading xslF345X03/form454581_20121116051858-.xml…